Profile for Kamada Ltd. (KMDA)
« Back to company indexKMDA Chatter Timeline
Stock Ticker for KMDA
Most Active Tweeters for KMDA
| User | Tweets |
|---|---|
| @chaffeybreeze | 5 |
| @IRAMarketReport | 5 |
| @intercooleronli | 2 |
| @CFinancialNews | 2 |
| @pharma_sector | 2 |
Recent Tweets for KMDA
 |
@TheMarketsDaily Somewhat Positive Press Coverage Somewhat Unlikely to Affect Kamada $KMDA Share Price https://t.co/upmdBnhNm8 September 25th 2017, 12:09pm |
 |
@IRAMarketReport Kamada $KMDA and Mirna Therapeutics $SYBX Head to Head Review https://t.co/v4mINRyiN4 September 25th 2017, 9:09am |
 |
@CFinancialNews Kamada $KMDA and Mirna Therapeutics $SYBX Head to Head Review https://t.co/kWd9iCBFJx September 25th 2017, 9:09am |
 |
@chaffeybreeze Kamada $KMDA and Mirna Therapeutics $SYBX Head to Head Review https://t.co/BRVrznEgBw September 25th 2017, 8:09am |
 |
@intercooleronli Kamada $KMDA and Mirna Therapeutics $SYBX Head to Head Review https://t.co/4x7xcolqdK September 25th 2017, 8:09am |
|
@intercooleronli Analyzing Transition Therapeutics $TTHI and Kamada $KMDA https://t.co/tetMZPZPGs September 23rd 2017, 12:09am |
|
@IRAMarketReport Analyzing Transition Therapeutics $TTHI and Kamada $KMDA https://t.co/heF6NmH9xS September 23rd 2017, 12:09am |
|
@chaffeybreeze Analyzing Transition Therapeutics $TTHI and Kamada $KMDA https://t.co/gU7Dni3rXd September 23rd 2017, 12:09am |
|
@CFinancialNews Analyzing Transition Therapeutics $TTHI and Kamada $KMDA https://t.co/jHHXOBSip3 September 23rd 2017, 12:09am |
|
@IRAMarketReport Edmond DE Rothschild Holding S.A. Increases Stake in Kamada Ltd. $KMDA https://t.co/poJ903Gb7j September 21st 2017, 9:09am |
|
@chaffeybreeze Edmond DE Rothschild Holding S.A. Increases Stake in Kamada Ltd. $KMDA https://t.co/MD4eeVjJnA September 21st 2017, 9:09am |
 |
@MarginHunt John Paulson owns shares of Kamada Ltd. $KMDA and expects a 19% jump https://t.co/OOXqT29eXl https://t.co/DeUCKXCpAl September 20th 2017, 4:09am |
|
@IRAMarketReport Kamada $KMDA Receiving Favorable Press Coverage, Analysis Finds https://t.co/W9HsRV2Cmm September 19th 2017, 9:09am |
|
@chaffeybreeze Kamada $KMDA Receiving Favorable Press Coverage, Analysis Finds https://t.co/hZOR5Q8YbZ September 19th 2017, 9:09am |
 |
@pharma_sector #Kamada Announces CFO Transition . Read more: https://t.co/h3nheNxNjO $KMDA September 18th 2017, 3:09pm |
|
@pharma_sector #Kamada Announces CFO Transition. Read more: https://t.co/Or5PlindVg $KMDA September 18th 2017, 12:09pm |
 |
@edtaussig RT @BioStocks: $KMDA Deputy CEO and CFO Resigns September 18th 2017, 10:09am |
 |
@Briefingcom $KMDA: Kamada announces that Deputy CEO & CFO Gil Efron recently informed the Company of his plan to leave at the... https://t.co/EWduvQDHy6 September 18th 2017, 9:09am |
 |
@stocknewsdotcom $KMDA Deputy CEO & CFO to step down at year-end https://t.co/m1aAEv67Sy September 18th 2017, 7:09am |
 |
@BioStocks $KMDA Deputy CEO and CFO Resigns September 18th 2017, 7:09am |
 |
@thegunnerab $KMDA Brosh Capital Partners average purchase price for their 6.2% is $5,15. You can buy cheaper today ! September 14th 2017, 8:09am |
 |
@jfais20 $KMDA Brosh Capital Partners reports 6.2% stake , says shares undervalued September 13th 2017, 6:09pm |
|
@IRAMarketReport 6.2% Stake of Kamada Ltd. $KMDA Held by Brosh Capital Partners L.P. https://t.co/f46VH2hPp5 September 13th 2017, 3:09pm |
|
@chaffeybreeze 6.2% Stake of Kamada Ltd. $KMDA Held by Brosh Capital Partners L.P. https://t.co/XgIfziOOhc September 13th 2017, 3:09pm |
 |
@fintel_io Brosh Capital Partners L.p. has filed a new activist 13D, reporting 6.2% ownership in $KMDA - https://t.co/xqxV1Zp4d7 September 13th 2017, 3:09pm |
 |
@sfef84 $KMDA new 13D popping on vol here 4.55 September 13th 2017, 3:09pm |
 |
@confcalltran Esther Deutsch just provided an update on activist position in Kamada https://t.co/rjVfbpuACO $KMDA September 13th 2017, 2:09pm |
 |
@WatchlistN Favorable News Coverage Somewhat Unlikely to Impact Kamada $KMDA Share Price https://t.co/C9vi7SOTBA September 13th 2017, 10:09am |
 |
@SPNewsAnalysis Syros Pharmaceuticals $SYRS vs. Kamada $KMDA Head to Head Contrast https://t.co/WMfpbAUjaR September 10th 2017, 3:09am |
 |
@storminvestor Syros Pharmaceuticals $SYRS vs. Kamada $KMDA Head to Head Contrast https://t.co/yeF0mbY4KT September 10th 2017, 3:09am |
|
@pharma_sector #Kamada to Present Corporate Overview at Two Investor Conferences in September. Read more: https://t.co/VVdMy5RGU1 $KMDA September 8th 2017, 11:09pm |
|
@pharma_sector #Kamada to Present Corporate Overview at Two Investor Conferences in September. Read more: https://t.co/FyHpNOwSt8 $KMDA September 8th 2017, 11:09pm |
|
@pharma_sector #Kamada : to Present Corporate Overview at Two Investor Conferences in September. Read more: https://t.co/whqAJfFSbU $KMDA September 8th 2017, 10:09pm |
|
@pharma_sector #Kamada Says FDA Issued Letter Stating that it Continues to Have Concerns and Questions Abo... Read more: https://t.co/CpwwYMztlX $KMDA September 8th 2017, 1:09pm |
|
@pharma_sector #Kamada Announces Full Exercise Of Underwriters??? Option To Purchase Additional Shares . Read more: https://t.co/sCOIrQX5gG $KMDA September 8th 2017, 8:09am |
|
@pharma_sector #Kamada Announces Full Exercise of Underwriters' Option to Purchase Additional Shares. Read more: https://t.co/rrzvg4TOWC $KMDA September 8th 2017, 8:09am |
 |
@LifeSciAdvisors Kamada $KMDA: Presenting Corporate Overview at Two Investor Conferences in September https://t.co/NtwGcY60WW September 7th 2017, 11:09am |
|
@intercooleronli Analyzing Syros Pharmaceuticals $SYRS & Kamada $KMDA https://t.co/kwvBgMQP6I September 7th 2017, 10:09am |
 |
@AmericanBanking Analyzing Syros Pharmaceuticals $SYRS & Kamada $KMDA https://t.co/ZU9Gtscodk September 7th 2017, 10:09am |
|
@AmericanBanking $SYRS, $KMDA - Analyzing Syros Pharmaceuticals #SYRS & Kamada #KMDA https://t.co/zrM7hsp0ya September 7th 2017, 10:09am |
|
@CFinancialNews Analyzing Syros Pharmaceuticals $SYRS & Kamada $KMDA https://t.co/Om4JUDCyCy September 7th 2017, 10:09am |
|
@confcalltran Kamada To Present Corporate Overview At Two Investor Conferences In September https://t.co/8wtMqiO112 $KMDA September 7th 2017, 7:09am |
|
@Briefingcom $KMDA: Kamada announces a collaboration for advanced research on Alpha-1 Antitrypsin with a focus on mechanism of... https://t.co/DwzSngdzhw September 6th 2017, 9:09am |
|
@confcalltran Kamada Announces Collaboration With Bgn Technologies For Advanced Alpha- https://t.co/RlZo9ATD1I $KMDA September 6th 2017, 7:09am |
|
@stocknewsdotcom $KMDA Announces a collaboration for advanced research on Alpha-1 Antitrypsin with a focus on mechanism of action w… https://t.co/0Qw2wHL8tC September 6th 2017, 7:09am |
 |
@StockNewsWires $KMDA: Kamada Announces Collaboration with BGN Technologies for …: https://t.co/OXSKzDxc6p September 6th 2017, 7:09am |
 |
@stockboardinc $KMDA Kamada Announces Collaboration with BGN Technologies for Advanced Alpha-1 Antitrypsin Research with ... - https://t.co/HtRfuLx5Ci September 6th 2017, 7:09am |
 |
@midetimes Kamada Ltd. $KMDA Downgraded by ValuEngine to “Sell” https://t.co/JMhQvEKCMT September 2nd 2017, 5:09pm |
 |
@bnbdailynews Kamada Ltd. $KMDA Downgraded by ValuEngine to “Sell” https://t.co/Qx2yycIFVf September 2nd 2017, 5:09pm |
 |
@WKRBNews Kamada Ltd. $KMDA Downgraded by ValuEngine to “Sell” https://t.co/LPUacQdcka September 2nd 2017, 5:09pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.